Published in Int J Eat Disord on May 01, 2004
Experimental test of the affect-regulation theory of bulimic symptoms and substance use: a randomized trial. Int J Eat Disord (2007) 1.16
Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial. Br J Psychiatry (2011) 1.06
The changing "weightscape" of bulimia nervosa. Am J Psychiatry (2012) 0.96
Current and emerging directions in the treatment of eating disorders. Subst Abuse (2012) 0.92
Cultural Adaptation of a Cognitive Behavior Therapy Guided Self-Help Program for Mexican American Women With Binge Eating Disorders. J Couns Dev (2012) 0.86
Eating disorders: National Institute of Mental Health's perspective. Am Psychol (2007) 0.83
Management of anorexia and bulimia nervosa: An evidence-based review. Indian J Psychiatry (2010) 0.80
Bulimia nervosa. BMJ Clin Evid (2010) 0.78
Bulimia nervosa. BMJ Clin Evid (2008) 0.76
GAMBLINGLESS: FOR LIFE study protocol: a pragmatic randomised trial of an online cognitive-behavioural programme for disordered gambling. BMJ Open (2017) 0.75
How many therapists? Practical guidance on investigating therapist effects in randomized controlled trials for eating disorders. Int J Eat Disord (2012) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Coming to terms with risk factors for eating disorders: application of risk terminology and suggestions for a general taxonomy. Psychol Bull (2004) 3.39
The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int (2013) 2.73
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64
Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder. Neuroimage (2011) 2.05
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry (2009) 1.87
Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology (2002) 1.82
Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med (2007) 1.77
Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. J Clin Psychiatry (2006) 1.77
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry (2003) 1.66
Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol (2007) 1.64
Evaluation of the Two-Way Communication Checklist as a clinical intervention. Results of a multinational, randomised controlled trial. Br J Psychiatry (2004) 1.61
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (2010) 1.61
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry (2007) 1.60
Anger attacks in depression--evidence for a male depressive syndrome. Psychother Psychosom (2005) 1.55
The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. Eur J Nucl Med Mol Imaging (2008) 1.55
International Consensus Group on Bipolar I Depression Treatment Guidelines. J Clin Psychiatry (2004) 1.50
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder. Eur Arch Psychiatry Clin Neurosci (2012) 1.49
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract (2012) 1.49
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry (2013) 1.48
Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry (2006) 1.46
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry (2004) 1.44
The serotonin-1A receptor in anxiety disorders. Biol Psychiatry (2009) 1.40
Estimated prevalence of compulsive buying in Germany and its association with sociodemographic characteristics and depressive symptoms. Psychiatry Res (2010) 1.33
The prevalence of compulsive hoarding and its association with compulsive buying in a German population-based sample. Behav Res Ther (2009) 1.33
Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry (2002) 1.24
Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatry (2002) 1.23
Differential modulation of the default mode network via serotonin-1A receptors. Proc Natl Acad Sci U S A (2012) 1.22
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry (2002) 1.19
Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology. Drug Alcohol Depend (2004) 1.19
Case studies in reproducibility. Brief Bioinform (2011) 1.18
Fully exploratory network independent component analysis of the 1000 functional connectomes database. Front Hum Neurosci (2012) 1.18
Psychiatric disorders in bariatric surgery candidates: a review of the literature and results of a German prebariatric surgery sample. Gen Hosp Psychiatry (2009) 1.18
Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol (2003) 1.17
A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity. Hum Mol Genet (2006) 1.16
Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol Alcohol (2002) 1.14
Evidence-based German guidelines for surgery for obesity. Int J Colorectal Dis (2011) 1.12
The application of ecological momentary assessment to the study of night eating. Int J Eat Disord (2007) 1.10
Regional sex differences in grey matter volume are associated with sex hormones in the young adult human brain. Neuroimage (2009) 1.08
Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol (2007) 1.07
Loss of control eating and psychological maintenance in children: an ecological momentary assessment study. Behav Res Ther (2008) 1.07
Mixtures of regression models for time course gene expression data: evaluation of initialization and random effects. Bioinformatics (2009) 1.06
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. World J Biol Psychiatry (2011) 1.06
The influence of eating behavior and eating pathology on weight loss after gastric restriction operations. Obes Surg (2005) 1.06
How frequent are eating disturbances in the population? Norms of the eating disorder examination-questionnaire. PLoS One (2012) 1.06
Psychological and dietary treatments of binge eating disorder: conceptual implications. Int J Eat Disord (2003) 1.05
Bright-light therapy in the treatment of mood disorders. Neuropsychobiology (2011) 1.05
Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. Neuroimage (2009) 1.04
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry (2002) 1.04
Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine. Int Clin Psychopharmacol (2007) 1.04
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry (2011) 1.03
Placebo-controlled studies in depression: necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci (2003) 1.03
Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci (2012) 1.02
Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled Trials. Psychother Psychosom (2015) 1.01
Web-based data collection yielded an additional response bias--but had no direct effect on outcome scales. J Clin Epidemiol (2012) 1.00
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry (2004) 0.99
A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Eur Neuropsychopharmacol (2007) 0.99
Meta-analysis: fact or fiction? How to interpret meta-analyses. World J Biol Psychiatry (2011) 0.99
Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy. Biol Psychiatry (2005) 0.98
Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology (2007) 0.98
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder. Int Clin Psychopharmacol (2011) 0.97
Microstructural abnormalities of the posterior thalamic radiation and the mediodorsal thalamic nuclei in females with anorexia nervosa--a voxel based diffusion tensor imaging (DTI) study. J Psychiatr Res (2012) 0.97
gcExplorer: interactive exploration of gene clusters. Bioinformatics (2009) 0.97
Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs (2012) 0.96
Compulsive buying. Am J Addict (2015) 0.96
Switching antidepressant class does not improve response or remission in treatment-resistant depression. J Clin Psychopharmacol (2011) 0.96
A quantitative comparison of functional MRI cluster analysis. Artif Intell Med (2004) 0.95
The emergence of eating pathology after bariatric surgery: a rare outcome with important clinical implications. Int J Eat Disord (2011) 0.95
Prevalence of mental disorders in normal-weight and obese individuals with and without weight loss treatment in a German urban population. J Psychosom Res (2006) 0.95
Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling. Neuroimage (2012) 0.95
Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol. Psychopharmacology (Berl) (2002) 0.94
A highly parallelized framework for computationally intensive MR data analysis. MAGMA (2011) 0.94
Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol (2012) 0.94
RGG: a general GUI Framework for R scripts. BMC Bioinformatics (2009) 0.94
Recurrent brief depression revisited. Int Rev Psychiatry (2005) 0.93
Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology (2007) 0.93
Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders. J Neurosci (2010) 0.93
Modelling human immunodeficiency virus ribonucleic acid levels with finite mixtures for censored longitudinal data. J R Stat Soc Ser C Appl Stat (2012) 0.93
Normative database of the serotonergic system in healthy subjects using multi-tracer PET. Neuroimage (2012) 0.92
Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Hum Brain Mapp (2009) 0.92
[Compulsive buying and psychiatric comorbidity]. Psychother Psychosom Med Psychol (2008) 0.92
Cognitive behavioral therapy for compulsive buying disorder. Behav Res Ther (2006) 0.91
RESCALE: Voxel-specific task-fMRI scaling using resting state fluctuation amplitude. Neuroimage (2012) 0.91
Body mass index or waist circumference: which is the better predictor for hypertension and dyslipidemia in overweight/obese children and adolescents? Association of cardiovascular risk related to body mass index or waist circumference. Horm Res Paediatr (2013) 0.91
The role of pharmacogenetics in the treatment of depression and anxiety disorders. Int Clin Psychopharmacol (2009) 0.91
The eating disorders medicine cabinet revisited: a clinician's guide to appetite suppressants and diuretics. Int J Eat Disord (2003) 0.91
Inhibitory control and decision making under risk in bulimia nervosa and binge-eating disorder. Int J Eat Disord (2013) 0.91
Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions. Int J Neuropsychopharmacol (2010) 0.91
Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET. Neuroimage (2008) 0.90
White matter hyperintensities and chronicity of depression. J Psychiatr Res (2005) 0.90
Imaging treatment effects in depression. Rev Neurosci (2012) 0.90
A comparison of the Major Depression Inventory (MDI) and the Beck Depression Inventory (BDI) in severely depressed patients. Int J Psychiatry Clin Pract (2010) 0.90
Agomelatine in the treatment of seasonal affective disorder. Psychopharmacology (Berl) (2006) 0.90